Human facial allotransplantation: a 2-year follow-up study

The Lancet

Volumn 372, Issue 9639, 2008, Pages 631-638

  Guo, Shuzhong ^a   Han, Yan ^a   Zhang, Xudong ^a   Lu, Binglun ^a   Yi, Chenggang ^a   Zhang, Hui ^a   Ma, Xianjie ^a   Wang, Datai ^a   Yang, Li ^a   Fan, Xing ^a   Liu, Yunjing ^a   Lu, Kaihua ^a   Li, Huiyuan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALLICIN; CEFTRIAXONE; CORTICOSTEROID; FAMOTIDINE; GLUCURONOLACTONE; HUMAN IMMUNOGLOBULIN; HUMANISED INTERLEUKIN 2 RECEPTOR MONOCLONAL ANTIBODY; IMMUNOMODULATING AGENT; MEDILAC S; METHYLPREDNISOLONE; METRONIDAZOLE; MIYA BMP; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OMEPRAZOLE; PREDNISONE; PROBIOTIC AGENT; TACROLIMUS; VANCOMYCIN;

ABSENCE OF SIDE EFFECTS; ACUTE GRAFT REJECTION; ADULT; ALLOTRANSPLANTATION; ANASTOMOSIS; ARTICLE; CASE REPORT; CHINA; COMPOSITE GRAFT; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; FACE INJURY; FACE SURGERY; FACIAL ALLOTRANSPLANTATION; FOLLOW UP; GRAFT SURVIVAL; HUMAN; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INFECTION; INJURY SEVERITY; INTESTINE FLORA; KIDNEY FUNCTION; LIVER FUNCTION; MALE; MANDIBLE; MAXILLARY SINUS; NOSE; PAROTID GLAND; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RECIPIENT; SIDE EFFECT; SURGICAL TECHNIQUE; T LYMPHOCYTE SUBPOPULATION; TISSUE TRANSPLANTATION; UPPER LIP; ZYGOMA;

EID: 49649108772     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61276-3     Document Type: Article

References (37)

1. Siemionow M., Ozmen S., and Demir Y. Prospects for facial allograft transplantation in humans. Plast Reconstr Surg 113 (2004) 1421-1428
2. Hettiaratchy S., and Butler P.E. Face transplantation-fantasy or the future?. Lancet 360 (2002) 5-6
3. Dubernard J.M., Owen E., Herzberg G., et al. The first transplantation of a hand in humans. Early results. Chirurgie 124 (1999) 358-365
4. Brown C.S., Gander B., Cunningham M., et al. Ethical considerations in face transplantation. Int J Surg 5 (2007) 353-364
5. Morris P., Bradley A., Doyal L., et al. Face transplantation: a review of the technical, immunological, psychological and clinical issues with recommendations for good practice. Transplantation 83 (2007) 109-128
6. Okie S. Facial transplantation: brave new face. N Engl J Med 354 (2006) 889-894
7. Devauchelle B., Badet L., Lengele B., et al. First human face allograft: early report. Lancet 368 (2006) 203-209
8. Dubernard J.M., Lengele B., Morelon E., et al. Outcomes 18 months after the first human partial face transplantation. N Engl J Med 357 (2007) 2451-2460
9. Kerman R.H., Susskind B., Buelow R., et al. Correlation of ELISA-detected IgG and IgA anti-HLA antibodies in pretransplant sera with renal allograft rejection. Transplantation 62 (1996) 201-205
10. Kanitakis J., Petruzzo P., Jullien D., et al. Pathological score for the evaluation of allograft rejection in human hand (composite tissue) allotransplantation. Eur J Dermatol 15 (2005) 235-238
11. Thomas A., Obed V., Murarka A., and Malhotra G. Total face and scalp replantation. Plast Reconstr Surg 102 (1998) 2085-2087
12. Wilhelmi B.J., Kang R.H., Movassaghi K., Ganchi P.A., and Lee W.P. First successful replantation of face and scalp with single-artery repair: model for face and scalp transplantation. Ann Plast Surg 50 (2003) 535-540
13. Ulusal B.G., Ulusal A.E., Ozmen S., Zins J.E., and Siemionow M.Z. A new composite facial and scalp transplantation model in rats. Plast Reconstr Surg 112 (2003) 1302-1311
14. Dez L.E.B., Santamaria A., Romero T., and Caldero D.F. Experimental model of facial transplant. Plast Reconstr Surg 110 (2002) 1374-1375
15. Demir Y., Ozmen S., Klimczak A., Mukherjee A.L., and Siemionow M. Tolerance induction in composite facial allograft transplantation in the rat model. Plast Reconstr Surg 114 (2004) 1790-1801
16. Hettiaratchy S., and Butler P.E. Tolerance induction in composite facial allograft transplantation in the rat model. Plast Reconstr Surg 117 (2006) 1043-1044
17. Siemionow M., Demir Y., Mukherjee A., and Klimczak A. Development and maintenance of donor-specific chimerism in semi-allogenic and fully major histocompatibility complex mismatched facial allograft transplants. Transplantation 79 (2005) 558-567
18. Ulusal A.E., Ulusal B.G., Hung L.M., and Wei F.C. Establishing a composite auricle allotransplantation model in rats: introduction to transplantation of facial subunits. Plast Reconstr Surg 116 (2005) 811-817
19. Siemionow M.Z., Demir Y., Sari A., and Klimczak A. Facial tissue allograft transplantation. Transplant Proc 37 (2005) 201-204
20. Siemionow M., and Agaoglu G. The issue of "facial appearance and identity transfer" after mock transplantation: a cadaver study in preparation for facial allograft transplantation in humans. J Reconstr Microsurg 22 (2006) 329-334
21. Siemionow M., Agaoglu G., and Unal S. A cadaver study in preparation for facial allograft transplantation in humans: part II. Mock facial transplantation. Plast Reconstr Surg 117 (2006) 876-885
22. Zhou Y.C., and Cecka J.M. Sensitization in renal transplantation. Clin Transpl (1991) 313-323
23. Lee K.W., Kim S.J., Lee D.S., et al. Effect of panel-reactive antibody positivity on graft rejection before or after kidney transplantation. Transplant Proc 36 (2004) 2009-2010
24. Singh D., Kiberd B.A., West K.A., et al. Importance of peak PRA in predicting the kidney transplant survival in highly sensitized patients. Transplant Proc 35 (2003) 2395-2397
25. Ishida H., Tanabe K., Miyamoto N., et al. Need for preoperative antibody elimination in panel reactive antibody assay (pra) positive patients; a clinicopathological study. Transplantation 78 (2004) 54
26. Tanaka Y., Ohdan H., Onoe T., et al. Low incidence of acute rejection after living-donor liver transplantation: immunologic analyses by mixed lymphocyte reaction using a carboxyfluorescein diacetate succinimidyl ester labeling technique. Transplantation 79 (2005) 1262-1267
27. Pei G., Gu L., and Yu L. A preliminary report of two cases of human hand allograft. Zhonghua Yi Xue Za Zhi 80 (2000) 417-421
28. Ma Z.L., Pei G.X., Zhu L.J., et al. Effect of X-ray irradiation on limb allograft rejection in adult rats. Di Yi Jun Yi Da Xue Xue Bao 22 (2002) 509-511
29. Kvernmo H.D., Gorantla V.S., Gonzalez R.N., and Breidenbach III W.C. Hand transplantation. A future clinical option?. Acta Orthop 76 (2005) 14-27
30. Mottershead M., and Neuberger J. Daclizumab. Expert Opin Biol Ther 7 (2007) 1583-1596
31. Bhorade S.M., Jordan A., Villanueva J., et al. Comparison of three tacrolimus-based immunosuppressive regimens in lung transplantation. Am J Transplant 3 (2003) 1570-1575
32. Light J.A., Sasaki T.M., Ghasemian R., Barhyte D.Y., and Fowlkes D.L. Daclizumab induction/tacrolimus sparing: a randomized prospective trial in renal transplantation. Clin Transplant 16 (2002) 30-33
33. Ahsan N., Holman M.J., Jarowenko M.V., Razzaque M.S., and Yang H.C. Limited dose monoclonal IL-2R antibody induction protocol after primary kidney transplantation. Am J Transplant 2 (2002) 568-573
34. Kaplan B., West P., Neeley H., et al. Use of low dose tacrolimus, mycophenolate mofetil and maintenance IL-2 receptor blockade in an islet transplant recipient. Clin Transplant 22 (2008) 250-253
35. Yagmurdur M.C., Sevmis S., Emiroglu R., Moray G., Bilgin N., and Haberal M. Tacrolimus conversion in kidney transplant recipients: analysis of 107 patients. Transplant Proc 36 (2004) 144-147
36. Copstein L.A., Zelmanovitz T., Goncalves L.F., and Manfro R.C. Posttransplant diabetes mellitus in cyclosporine-treated renal allograft patients: a case-control study. Transplant Proc 36 (2004) 882-883
37. Moore R., Ravindran V., and Baboolal K. The burden of new-onset diabetes mellitus after transplantation. Clin Transplant 20 (2006) 755-761